Loading company…
Readline provides immobilized enzyme technology and synthetic biotechnology services across several industries.
Founded in 2017 and based in Shenzhen, China, Readline provides biotechnology products and services for health, consumer, and agriculture markets through its ReBioHub platform. Its product areas include skincare, nutrition, animal health, biomedicine, green agriculture, and biomaterials. The company raised Series C funding in February 2025 from CoStone Capital and Green Pine Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in